̽ѡ

Anna Mia Ekström

Anna Mia Ekström

ʰǴڱǰ/Öä첹
Telefon: +46852482824
ö: Widerströmska huset Tomtebodavägen 18 A, plan 3, 17165 Solna
Postadress: K9 Global folkhälsa, K9 GPH Ekström, 171 77 Stockholm
Del av:

Om mig

  • Klinisk professor i global infektionsepidemiologi med fokus på HIV och gruppledare för forskargruppen Global and Sexual Health (GloSH) vid institutionen för global folkhälsa.
    Kliniskt aktiv överläkare i infektionsmedicin, 25 års erfarenhet av kliniskt arbete (infektionsläkare 2000-2020 på Karolinska Univ. Sjukhuset, 2020-idag på Södersjukhuset (SöS), 30 % klinisk praktik (70% forskning).
    Master of Public Health (MPH) kvantitativa metoder från Harvard School of Public Health 1995, läkarexamen (MD), 1997, från ̽ѡ (KI), PhD medicinsk epidemiologi 2000.

Forskningsbeskrivning

  • De senaste 25 åren lett multipla stora internationella forskningsprojekt i Europa, Afrika och Asien, med fokus på sexuell och reproduktiv hälsa och rättigheter (SRHR), hiv och ”emerging infections” (ebola, zika, covid-19, mpox), vaccintillgång, könsbaserat våld, sexuellt riskbeteende, hälsosystem, mor-barnhälsa (morbarns-smitta av hiv), utsatta grupper avseende hiv/STI  s.k. key populations tex ungdomar, migranter, injektions-missbrukare, HBTQI+, hälso- och sjukvårdssystem, prevention och implementeringsforskning, effekter av hälsopolicy på hälsa och vård, global vaccin policy och vaccintillgång, hälsa och demografisk surveillance/epidemiologi, effekten av olika länders normer och värderingar kring gender och SRHR på ungas hälsa och kvinnors ekonomiska empowerment.
     
    Expert -& ledningsuppdrag
     
    Leder forskargruppen Global & Sexuell hälsa (GloSH) KI /en/gph/global-and-sexual-health-glosh med >50 tvärvetenskapliga internationella forskare, hemvist för prof. Hans Roslings undervisningsarv.
     
    Ordförande för WHO:s tekniska rådgivande grupp (TAG) för tillgång till vacciner på globala marknader MVAC  
    Sveriges representant, HERAs rådgivande grupp (myndigheten för beredskap och insatser vid hälsokriser), EU-kommissionen
    Expert på Covax Independent Allocation of Vaccines Group (IAVG) för global tilldelning av covid-19-vaccin, WHO
    Ordförande i Sidas vetenskapliga råd, Styrelsen för internationellt utvecklingssamarbete (Sida)
    Sakkunnig/medlem i Sveriges vetenskapliga referensgrupp för tillgång till covid-19 vacciner (Utrikesdepartementet)
    Expertrådgivare om vaccin mot covid-19, Socialstyrelsen
    Styrelseledamot Centrum för hälsokriser, Stockholm
    Ledare KI:s arbetsgrupp för covid-19 och folkhälsa samt resursgruppen för covid-19 och global hälsa
    Ledamot, Etikrådet, ̽ѡ
    Ledare för forskargruppen Global & Sexuell hälsa (GloSH) /en/gph/global-and-sexual-health-glosh på KI med @50 tvärvetenskapliga internationella forskare, och min grupp är hemvisten för prof. Hans Roslings undervisningsarv
     
    Övriga expertuppdrag: 
    Socialstyrelsen, Smittskyddsinstitutet, Migrationskliniken, Stockholms Sprututbyte, Svenska Läkaresällskapet, Medicinska forskningsrådet, Noaks Arks HIV Foundation, Aids Accountability International, Global Challenges think tank, KI:s Etiska råd, KI:s internationaliseringsråd, Läkare mot aids, HIV Outcomes, INDEPTH – nätverk av hälso- och demografiska övervakningsplatser (HDSS) i 52 låg- och medelinkomstländer

Undervisning

  • Handlett 27 PhD studenter till disputation 
      
    Disputerade doktorander som huvudhandledare (14)
    2024: Veronica Tirado: Goodluck Willey Lyatuu & Muslima Ejaz, 2020: Niklas Karlsson, 2019: Mia Liisa van der Kop & Galit Zeluf Andersson 2017: Helga Naburi & Keshab Deuba, 2013: Yanga Zembe, 2012: Elin Larsson 2011: Ziad El-Khatib
    2010: Anders Ragnarsson & Christian Unge 2006: Daniel Kabonge Kaye (joint degree KI och Makerere University)
      
    Disputerade doktorander som bihandledare (13) 
    2024: Katrine de Angeles 2023: Sara Causevic, 2022: Rocio Enriquez & Björn Nordberg, 2019: Celia Pareya, 2018: Michele Santacatterina, 2014: Matilda Ngarina, 2013: Hanani Tabana & Abela Mpobela Agnarsson, 2011: Patricia Opondo Awiti Ujiji & Mohamadi Lubega (gemensam examen KI/ Makerere Univ., Uganda), 2010: Jolly Beyeza (joint degree KI & Makerere University, Uganda), 2007: Stefan Hanson
     
    Pågående handledning av doktorander (N=15)
     
    Huvudhandledare (2) Leo Ziegel, Carl-Fredrik Sjöland
     
    Bihandledare (13): Yauheni Luksha, Emmanuel Kyasanku, Winfred Mwangi, Roseline Urrio, Frida Larsson, Miriam Hartmann, Robert Ssekubugu, Karin Båge, Yunia Mayanja, Lovisa Hellsten, Malin Falk Wärmå, Jonathan Mwangi
     
    Undervisning
     
    2000- 2025: 25 år av undervisning och kurs-samordning, sammanlagt upp till >950 timmar på grundnivå och >400 timmar på grundnivå och 400 timmar på grundnivå 
     
    2016: Massive Open Online Course (MOOC): En introduktion till global hälsa.
    2013-2023: Kursansvarig. SVK tvärvetenskaplig grundkurs i Global Hälsa 7, 5 hp, 75-100 studenter/termin x 2 /år från 11 KI-program
    2002-2025: Kursansvarig, 7, 5 hp "HIV-ett individuellt fokus ur ett globalt perspektiv"
    2011-2024: Kursansvarig 4, 5 hp, Master i global hälsa, Infektionsvetenskap KI
    2008-2009: Kursansvarig. "HIV/AIDS/Infektionssjukdomar" Master Global Health
    2006-2007: Kursansvarig, 4, 5 hp, Svensk-Etiopiska kursen i tropiska infektionssjukdomar/HIV, Karolinska Universitetssjukhuset
     
    Aktiv i media  >100 framträdanden i TV, radio, tidskrifter, podcasts på COVID-19, HIV, global hälsa, sexuell och reproduktiv hälsa och rättigheter (SRHR)

     

    ://sverigesradio.se/play/avsnitt/2524178#0

    ,   

Artiklar

  • Article: GLOBAL HEALTH ACTION. 2025;18(1):2484870
    Ziegel L; Sjoland CF; Nabunya E; Bulamba R; Kyasanku E; Mugamba S; Kigozi G; Daama A; Kigozi G; Miller AP; Hollander A-C; Hammarberg A; Nalugoda F; Ekstrom AM
  • Article: MAYO CLINIC PROCEEDINGS: DIGITAL HEALTH. 2025;3(3):100251
    Hellsten L; Ahlqvist VH; Nielsen AM; Branden G; Ekstrom AM; Kosidou K
  • Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2025;104(9):1627-1639
    Larsson FM; Nielsen A; Zeebari Z; Salazar M; Ekstrom AM; Moeller A
  • Journal article: SCIENTIFIC REPORTS. 2025;15(1):25076
    Ssekubugu R; Yeh PT; Nakawooya H; Ssempijja V; Kigozi G; Kagaayi J; Nalugoda F; Ekstrom AM; Nantume B; Serwadda D; Kreniske P; Zeebari Z; Moffa MA; Chang LW; Grabowski KM; Makumbi F; Nordenstedt H
  • Journal article: SSM - HEALTH SYSTEMS. 2025;4:100075
    De Angeles KJC; Storey S; Nordberg B; Kaguiri E; Dusabe-Richards J; Ekström AM; Were E; Skovdal M; Kågesten A
  • Article: BMC PSYCHIATRY. 2025;25(1):502
    Ziegel L; da Silva CE; Bulamba R; Daama A; Kigozi G; Miller AP; Kigozi G; Kyasanku E; Mugamba S; Hammarberg A; Ekstrom AM; Nalugoda F; Hollander A-C
  • Article: BMJ PUBLIC HEALTH. 2025;3(1):e001697
    Hartmann M; Stoner MCD; Storey S; Giovenco D; Zondi YZ; Qwabe N; Ekstrom AM; Pettifor AE; Bekker LG; Kagesten A
  • Article: CULTURE HEALTH & SEXUALITY. 2025;27(4):389-403
    Dennermalm N; Sjoland CF; Christiansen M; Schonnesson LN; Laine K; Kanon E; Suarez D; Ekstrom AM; Alvesson HM
  • Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2025;153:107373
    Petersen E; Hvid U; Tomori O; Pedersen AG; Wallinga J; Pebody R; Cenciarelli O; Aavitsland P; Van Laeken D; Andreasen V; Schneider U; Simonsen JK; Goedknegt MJF; Johannesen CK; Lundgren JD; Koch A; Soborg B; Ekstrom AM; Nohynek H; Aarestrup FM; Krause TG; Simonsen L
  • Article: INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH. 2025;24(1):53
    van der Kop ML; Båge K; Tirado V; Kågesten A; Puranen B; Sorcher R; Ekström AM; Larsson EC
  • Article: WOMEN'S HEALTH (LONDON, ENGLAND). 2025;21:17455057251326416
    Kurvinen M; Ekstrom AM; Deuba K
  • Article: GLOBAL HEALTH ACTION. 2024;17(1):2294592
    Causevic S; Ekstrom AM; Orsini N; Kagesten A; Stromdahl S; Salazar M
  • Article: GLOBAL HEALTH ACTION. 2024;17(1):2419160
    Ssekubugu R; Ndyanabo A; Makumbi F; Ekstroem AM; Beres L; Nalwoga Kigozi G; Nakawooya H; Ssekasanvu J; Wawer MJ; Nalugoda F; Sewankambo N; Ssempijja V; Nantume B; Serwadda D; Kigozi G; Gray RH; Chang LW; Grabowski MK; Nordenstedt H; Kagaayi J
  • Article: SEXUAL AND REPRODUCTIVE HEALTH MATTERS. 2024;32(1):2444725
    Bage K; Kagesten A; Uthman O; Salazar M; Puranen B; Svallfors S; Ekstrom AM; Litorp H
  • Article: BMJ OPEN. 2024;14(12):e080514
    McDonald JT; Fayzi B; Laktinah M; Ekstrom AM; Salazar M
  • Journal article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2024;34:ckae144.612
    Causevic S; Stromdahl S; Ekstrom AM; Berglund T; Persson KI; Salazar M
  • Journal article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2024;34(Suppl 3)
    HIV risks and transactional sex among Swedish-born MSM and foreign-born MSM in Sweden
  • Article: BMC PUBLIC HEALTH. 2024;24(1):2334
    Tirado V; Orsini N; Stromdahl S; Hanson C; Ekstrom AM
  • Article: BMJ PUBLIC HEALTH. 2024;2(2):e001090
    Arunda MO; Sorcher R; Canabarro APF; Svallfors S; Endler M; Gemzell-Danielsson K; Kagesten A; Ali M; Bahamondes L; Barreix M; Chou D; Gonsalves L; Johnston HB; Kiarie J; Kim CR; Narasimhan M; Pallitto C; Shah MG; Say L; Thorson A; Ekstrom AM; Larsson EC; Brizuela V
  • Journal article: REPRODUCTIVE HEALTH. 2024;21(1):90
    Svallfors S; Båge K; Ekström AM; Dessie Y; Wado YD; Fagbemi M; Larsson EC; Litorp H; Puranen B; Sundewall J; Uthman OA; Kågesten AE
  • Visa fler

Alla övriga publikationer

  • Review: REPRODUCTIVE HEALTH. 2025;22(1):89
    Ludecke LT; Ekman B; Arunda MO; Bulamba R; Daama A; Ekstrom AM; Kyasanku E; Larsson EC; Nkale J; Sundewall J
  • Editorial comment: BMJ-BRITISH MEDICAL JOURNAL. 2025;389:r661
    Fallah MP; Ekstrom AM; Ottersen OP; Tessema SK; Kaseya J
  • Corrigendum: FRONTIERS IN PUBLIC HEALTH. 2025;13:1597921
    Mayanja Y; Kayesu I; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Price M; Kosidou K; Ekstrom AM
  • Preprint: BIORXIV. 2025
    Bulamba R; Kyasanku E; Nalugoda F; Daama A; Nkale JM; Miller A; Byansi W; Namutundu J; Kigozi G; Nalwoga G; Balwanaki C; Watya S; Ekström AM; Mugamba S; Ndejjo R; Nakigozi G
  • Conference publication: JOURNAL OF ADVANCED NURSING. 2024;80:25-26
    Hartmann M; Stoner MCD; Storey S; Giovenco D; Zondi YZ; Qwabe N; Ekstroem AM; Pettifor A; Bekker L-G; Kagesten AE
  • Editorial comment: LANCET PLANETARY HEALTH. 2024;8(6):e347-e348
    Sorcher R; Arunda MO
  • Preprint: RESEARCH SQUARE. 2024
    Kop MVD; Båge K; Tirado V; Kågesten A; Puranen B; Sorcher R; Ekström AM; Larsson E
  • Letter: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(40):e2311969120
    Ekstrom AM; Ottersen OP
  • Meeting abstract: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2023;Volume 33 Supplement 2
    ‘‘Sweden has changed me’’: a qualitative study exploring sexual health needs of young male migrants
    Tewelde J
  • Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:173-174
    Mckay K; Wijnands J; Manouchehrinia A; Zhu F; Sereda P; Li J; Ye M; Trigg J; Kooij K; Ekstrom AM; Gisslen M; Hillert J; Hogg R; Tremlett H; Kingwell E
  • Preprint: RESEARCH SQUARE. 2023
    Båge K; Kågesten A; Fagbemi M; Utman O; Arunda MO; Puranen B-I; Ekström AM; Litorp H
  • Preprint: JMIR PREPRINTS. 2023
    Ssekubugu R; Ndyanabo A; Makumbi FE; Ekström AM; Beres L; Kigozi GN; Nakawooya H; Sssekasanvu J; Wawer MJ; Nalugoda F; Ssewankambo N; Ssempijja V; Nantume B; Serwadda D; Kigozi G; Gray RH; Chang LW; Grabowski KM; Nordenstedt H; Kagaayi J
  • Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:11-12
    Kingwell E; Manouchehrinia A; Zhu F; Mckay K; Li J; Ye M; Sereda P; Trigg J; Kooij K; Gisslen M; Ekstrom A; Hillert J; Hogg R; Tremlett H
  • Meeting abstract: JOURNAL OF IMMUNOLOGY. 2023;210(1):59.47
    Adamo S; Gao Y; Cai C; Muller TR; Niessl J; Akhirunnesa M; Ljunggren H-G; Sallberg M; Bergman P; Ekstrom A-M; Grifoni A; Sette A; Price DA; Buggert M
  • Preprint: SOCARXIV. 2023
    Svallfors S; Båge K; Ekström AM; Dessie Y; Wado YD; Fagbemi M; Larsson E; Litorp H; Puranen B; Sundewall J; Uthman O; Kågesten A
  • Preprint: JMIR PREPRINTS. 2023
    Shrestha R; Sapkota D; Mehra D; Ekström AM; Deuba K
  • Editorial comment: BMJ GLOBAL HEALTH. 2022;7(6):e008520
    Sundewall J; Bage K; Ekstrom AM; Puranen B; Litorp H; Uthman OA; Kagesten A
  • Editorial comment: BULLETIN OF THE WORLD HEALTH ORGANIZATION. 2021;99(12):910-912
    Ekstrom AM; Tomson G; Wanyenze RK; Bhutta ZA; Kyobutungi C; Binagwaho A; Ottersen OP
  • Editorial comment: BMJ-BRITISH MEDICAL JOURNAL. 2021;375:n2658
    Binagwaho A; Allotey P; Sangano E; Ekstrom AM; Martin K
  • Published conference paper: BMJ OPEN. 2021;11(11):e052176
    Ejaz M; Andersson S; Batool S; Ali T; Ekstrom AM
  • Visa fler

Forskningsbidrag

  • Swedish Research Council
    1 December 2024 - 30 November 2028
    Anal cancer incidence is rising globally. The International Anal Neoplasia Society recommends screening high-risk individuals using high-resolution anoscopy (HRA). However, most countries lack anal cancer screening guidelines, and HRA´s limited availability necessitates more efficient risk stratification methods. This project aims to advance anal cancer prevention through comprehensive register-based research and innovative biomarker discovery, with a particular focus on women, an understudied population in anal cancer research. Our objectives are to
    I) quantify Sweden´s anal cancer burden, stratifying by immune status to identify risk groups, II) evaluate the feasibility, cost-effectiveness, and acceptability of implementing international anal cancer screening guidelines for women with HIV, III) investigate DNA methylation markers´ predictive potential for precancerous anal lesion progression, and IV) assess circulating HPV DNA in plasma as a pre-diagnostic biomarker for anal cancer. We will utilize national registers and international collaborations through
    I) a nationwide register-based cohort study of anal cancer burden, II) a prospective register-based study of anal cancer screening in women with HIV, III) analysis of DNA methylation markers in anal samples, and IV) an international register-based nested case-control study of circulating HPV DNA. This project will generate crucial knowledge to inform evidence-based anal cancer prevention policies for high-risk groups.
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2023 - 31 December 2025
    Research problem and specific questionsYoung LGBTQ+ people i.e. Lesbians, Gays, Bisexuals, Transgender and Queer or Questioning persons have high risks for mental health problems but the reasons are unclear. This project will, therefore, focus on mental health of young LGBTQ+ people aged 16-29 years and vulnerable subgroups. Our research questions are:  Have the mental health outcomes of young LGBTQ+ people changed over time (2006-2021)? How has the COVID-19 pandemic impacted on the mental health of young LGBTQ people?How does the mental health of young LGBTQ+ people evolve as they transition into adulthood and what are the risk and protective factors?Why do bisexuals, transgender persons and persons with gender dysphoria have worse mental health than other LGBTQ+ subgroups i.e. gays and lesbians?What do young LGBTQ+ people think are the causes of mental ill-health among their peers and what support do they need? What works and is lacking in existing support to young LGBTQ+ people within first line health services and in society?Data and methodThe project has two parts. Part 1 is quantitative and based on the Stockholm Public Health Cohort (SPHC), a longitudinal (2002-2021) and population-based cohort (N≈140,000) with linked self-reported and registry data. The SPHC includes information on LGBTQ+ status and health, lifestyle and social factors, making it a world-unique dataset to study mental health of young LGBTQ+ people. Part 2 is qualitative and based on focus group discussions and in-depth interviews with young LGBTQ+ people.Plan for project realisationRegion Stockholm´s Centre for epidemiology and community medicine will host the project and has funded the SPHC. We ask for funds to cover costs for salaries for the project staff, data management and research- and conference travel.RelevanceAbout 15% of young people 16-29 years in Sweden (N=211,000) are LGBTQ+ persons, and young LGBTQ+ people have poorer mental health than their non-LGBTQ+ peers. It is, therefore, of great societal interest to address mental health inequities in this population. Our studies will span a very broad spectrum of young LGBTQ+ people, including gays, lesbians, bisexuals, transgender and queer persons and persons with gender dysphoria, making up a substantial share of young people in Sweden. The project will add new knowledge on the mental health of young LGBTQ+ people and help optimize the societal support and reduce inequality.
  • Swedish Research Council
    1 January 2023 - 31 December 2025
    Reports warn of serious pandemic harm on adolescent girls´ and young womens´ (AGYW, 13-24 yrs) lives including on their reproductive health in Africa. The specific aims of this project are to: 1) evaluate the impact of COVID-19 societal restrictions including school closures on unintended pregnancy and contraceptive use among AGYW, and estimate the long-term societal cost of these restrictions in Uganda (Study 1)
    2) explore AGYWs’ and other key stakeholders’ understanding of risk factors and underlying reasons for unintended pregnancies and low contraceptive use in the wake of the pandemic and beyond (Study 2)
    3) co-design a resilient intervention package aiming to reduce unintended pregnancies and improve contraceptive use among AGYW (Study 3)
    and 4) implement and test the intervention package using a cluster-randomized design. Data will be drawn from a large population cohort (rural/urban, &lt
    20,000 people) including intervention outcomes as well as additional quantitative and qualitative data collection. The project is expected to take 3 years and is a collaboration involving a very experienced and skilled team of Swedish and Ugandan researchers who earlier received a joint VR Links grant. The project is anticipated to yield high quality unique evidence about the impact of pandemic restrictions, including extensive school closures on AGYWs. The expected results will contribute to better resilience and pandemic preparedness in resource-poor health systems across Africa.
  • Swedish Research Council
    1 January 2023 - 31 December 2025
    Mental and alcohol use disorders in Africa are seriously understudied and underfinanced but have a huge impact on the burden of disease, human suffering and progress towards goals of leaving no-one behind and Agenda 2030. During COVID-related lockdowns, mental distress has increased in high-income settings but primary data from Africa and appropriate interventions are lacking. However mental health is closely interlinked with school closures, lost life opportunities, poverty, food insecurity. This large population-based study in Uganda aims to analyse the occurrence of the most common mental disorders (depression, anxiety) and alcohol abuse, and interactions with poverty, age, gender, reproductive health (HIV), urbanicity, food insecurity and partner violence. We will validate tools on stigma against mental illness and care seeking, and, assess the influence of the pandemic on access to care and prevention for mental and alcohol use disorders. This 3-year project will use longitudinal data from a cohort of 11,000 individuals aged 13-80 years before, during and after the pandemic. Based on our results we will suggest new policy guidelines for health care and community interventions to mitigate the impact of mental disorders and change prevailing discriminatory views of mental health in general. We build on a strong collaboration between Karolinska and AMBSO research organisation in Uganda overall aiming to optimize capacity for operational research in low-income contexts.
  • Swedish Research Council
    1 December 2022 - 30 November 2026
    In sub-Saharan Africa, adolescent girls and young women (AGYW) aged 15-24 years are more likely than older women to acquire HIV, and once pregnant, to transmit HIV to their infants and drop out of care. This highlights an urgent need to revisit the current one-size-fits-all model of prevention of mother-to-child transmission (PMTCT) programs. The purpose of this project is to optimize PMTCT care for AGYWs, and later their infants, in Tanzania – a setting where HIV remains endemic. To do so, we will use data from a large registry-based cohort (N≈13,800 with 22% 15-24 years) to investigate PMTCT service uptake, retention and health outcomes for AGYWs, as well as subsequent pregnancies and contraceptive use (study 1). We will combine this with a nested prospective cohort to identify social-structural predictors of these outcomes (study 2). We will utilize findings to develop (together with young women, health providers and managers) and prototype a package of micro-interventions that can be implemented in routine care to optimize PMTCT services for AGYWs. Using a cluster-randomized design, we will pilot-test the intervention package for feasibility and preliminary effect, as well as cost-effectiveness.  This five-year project is highly feasible considering the multidisciplinary team with skills and experience in both implementation and experimental research, and will contribute much-needed evidence to advance PMTCT care for AGYWs in line with their unique needs.
  • Sexual and reproductive health and rights for young people: how is the availability, content and quality of care affected by the digitization of healthcare during the covid-19 pandemic?
    Swedish Research Council
    1 December 2021 - 30 November 2024
  • Swedish Research Council
    1 December 2020 - 31 December 2022
  • Swedish Research Council
    1 January 2020 - 31 December 2022
  • Swedish Research Council
    1 January 2020 - 31 December 2021
  • Swedish Research Council
    1 January 2019 - 31 December 2021
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2018 - 31 December 2020
  • Swedish Research Council
    1 January 2018 - 31 December 2020
  • Swedish Research Council
    1 January 2017 - 31 December 2020
  • Swedish Research Council for Health Working Life and Welfare
    1 September 2016 - 31 August 2019
  • Swedish Research Council
    1 January 2016 - 31 December 2018
  • Swedish Research Council
    1 January 2014 - 31 December 2016
  • Swedish Research Council
    1 January 2013 - 31 December 2015
  • Swedish Research Council
    1 January 2011 - 31 December 2013

ԲäԾԲ

  • ʰǴڱǰ/Öä첹, Global folkhälsa, ̽ѡ, 2017-
  • ʰǴڱǰ/Öä첹, Klinisk forskning och utbildning, Södersjukhuset, ̽ѡ, 2024-2027

Examina och utbildning

  • Docent, Internationell hälsa, ̽ѡ, 2008
  • MEDICINE DOKTORSEXAMEN, Institutionen för medicinsk epidemiologi och biostatistik, ̽ѡ, 2000

Nyheter från KI

Kalenderhändelser från KI